Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Randomized Phase III Trial of Neoadjuvant Immunotherapy with Response-Adapted Treatment versus Standard-of-Care Treatment for Resectable Stage III/IV Cutaneous Squamous Cell Carcinoma

Disease Sites:

Head/Neck

Staging:

Phase III

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Choe, Jennifer

Scope:

National

Participating Institutions:

Vanderbilt University

Open Date:

07-24-2025

Trial Type:

Treatment

Protocol ID:

NRGHNHN014

National Clinical Trial ID:

NCT06568172

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available